Novartis Investigative Site

Chandler, Arizona 85225

0 studies enrolling now · 10 studies all time

What they study most

Acute Gouty Arthritis, Atherosclerosis, Cancer, Chronic Obstructive Pulmonary Disease, Diabetes, Genital Herpes, Hypertension, Lymphoma, Non-Hodgkin, Non-alcoholic Steatohepatitis (NASH), Stage 2 Hypertension

Studies at this site

• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis — Completed
• Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone — Stopped early
• Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) — Completed
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed
• Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients — Completed
• Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes — Stopped early
• Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes — Completed